Table 3. Associations between CD117 expression in EOC cells and clinicopathological features (N = 242).
CD117 expression, n (%) | ||||
Total N | negative | positive | p value | |
Age group | 0.632 | |||
≤59 | 121 | 109 (90.1) | 12 (9.9) | |
≥60 | 111 | 102 (91.9) | 9 (8.1) | |
missing | 10 | |||
FIGO stage | 0.267 | |||
I+II | 46 | 44 (95.7) | 2 (4.3) | |
III+IV | 196 | 176 (89.8) | 20 (10.2) | |
Differentiation grade | 0.306 | |||
well | 19 | 17 (89.5) | 2 (10.5) | |
moderately | 62 | 59 (95.2) | 3 (4.8) | |
poorly | 133 | 116 (87.2) | 22 (12.8) | |
missing | 28 | |||
Histological subtype | 0.439 | |||
serous | 163 | 149 (91.4) | 14 (8.6) | |
MUC+END+CLE | 48 | 42 (87.5) | 6 (12.5) | |
UND+MIX+others | 27 | 26 (96.3) | 1 (3.7) | |
missing | 4 |
MUC, Mucinous tumor; END, Endometrioid carcinoma; CLE, Clear cell carcinoma; UND, Undifferenciated tumor; MIX, Mixed epithelial tumor.